Neonatal diabetes caused by mutations in sulfonylurea receptor 1: Interplay between expression and Mg-nucleotide gating defects of ATP-sensitive potassium channels

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 12, 2010, Pages

  Zhou, Qing ^a   Garin, Intza ^b,c   Castaño, Luis ^b,c,d   Argente, Jesús ^e,f,g   Muñoz Calvo, Ma Teresa ^e,f,g   De Nanclares, Guiomar Perez ^b,c   Shyng, Show Ling ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b HOSPITAL DE CRUCES   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^e HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^f UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^g INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; MAGNESIUM; SULFONYLUREA; SULFONYLUREA RECEPTOR 1;

ARTICLE; CELL SURFACE; CHANNEL GATING; DIABETES MELLITUS; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; MOLECULAR MECHANICS; NEWBORN DISEASE; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 78650066409     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1231     Document Type: Article

References (20)

1. Aguilar-Bryan L, Bryan J 1999 Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev 20:101-135
2. Nichols CG 2006 KATP channels as molecular sensors of cellular metabolism. Nature 440:470-476
3. Ashcroft FM 2007 The Walter B. Cannon Physiology in Perspective Lecture, 2007. ATP-sensitive K+ channels and disease: from molecule to malady. Am J Physiol Endocrinol Metab 293:E880-E889
4. Babenko AP 2005 K(ATP) channels "vingt ans apres": ATG to PDB to mechanism. J Mol Cell Cardiol 39:79-98
5. Babenko AP, Bryan J 2003 SUR domains that associate with and gate KATP pores define a novel gatekeeper. J Biol Chem 278:41577-41580
6. Chan KW, Zhang H, Logothetis DE 2003 N-terminal transmembrane domain of the SUR controls trafficking and gating of Kir6 channel subunits. EMBO J 22:3833-3843
7. Flanagan SE, Patch AM, Mackay DJ, Edghill EL, Gloyn AL, Robinson D, Shield JP, Temple K, Ellard S, Hattersley AT 2007 Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. Diabetes 56:1930-1937
8. Vaxillaire M, Dechaume A, Busiah K, Cavé H, Pereira S, Scharfmann R, de Nanclares GP, Castano L, Froguel P, Polak M 2007 New ABCC8 mutations in relapsing neonatal diabetes and clinical features. Diabetes 56:1737-1741
9. Yan FF, Lin YW, MacMullen C, Ganguly A, Stanley CA, Shyng SL 2007 Congenital hyperinsulinism associated ABCC8 mutations that cause defective trafficking of ATP-sensitive K+ channels: identification and rescue. Diabetes 56:2339-2348
10. Flanagan SE, Clauin S, Bellanné-Chantelot C, de Lonlay P, Harries LW, Gloyn AL, Ellard S 2009 Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat 30:170-180
11. Pinney SE, MacMullen C, Becker S, Lin YW, Hanna C, Thornton P, Ganguly A, Shyng SL, Stanley CA 2008 Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations. J Clin Invest 118:2877-2886
12. Ellard S, Flanagan SE, Girard CA, Patch AM, Harries LW, Parrish A, Edghill EL, Mackay DJ, Proks P, Shimomura K, Haberland H, Carson DJ, Shield JP, Hattersley AT, Ashcroft FM 2007 Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects. Am J Hum Genet 81:375-382
13. Zerangue N, Schwappach B, Jan YN, Jan LY 1999 A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels. Neuron 22:537-548
14. Cartier EA, Conti LR, Vandenberg CA, Shyng SL 2001 Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy. Proc Natl Acad Sci USA 98:2882-2887
15. Masia R, De Leon DD, MacMullen C, McKnight H, Stanley CA, Nichols CG 2007 A mutation in the TMD0-L0 region of sulfonylurea receptor-1 (L225P) causes permanent neonatal diabetes mellitus (PNDM). Diabetes 56:1357-1362
16. Koster JC, Remedi MS, Dao C, Nichols CG 2005 ATP and sulfonylurea sensitivity of mutant ATP-sensitive K+ channels in neonatal diabetes: implications for pharmacogenomic therapy. Diabetes 54:2645-2654
17. Huopio H, Reimann F, Ashfield R, Komulainen J, Lenko HL, Rahier J, Vauhkonen I, Kere J, Laakso M, Ashcroft F, Otonkoski T 2000 Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. J Clin Invest 106:897-906
18. Lin CW, Lin YW, Yan FF, Casey J, Kochhar M, Pratt EB, Shyng SL 2006 Kir6.2 mutations associated with neonatal diabetes reduce expression of ATP-sensitive K+ channels: implications in disease mechanism and sulfonylurea therapy. Diabetes 55:1738-1746
19. Pratt EB, Yan FF, Gay JW, Stanley CA, Shyng SL 2009 Sulfonylurea receptor 1 mutations that cause opposite insulin secretion defects with chemical chaperone exposure. J Biol Chem 284:7951-7959
20. Gribble FM, Tucker SJ, Ashcroft FM 1997 The interaction of nucleotides with the tolbutamide block of cloned ATP-sensitive K+ channel currents expressed in Xenopus oocytes: a reinterpretation. J Physiol 504:35-45